Avanos Medical (NYSE:AVNS – Get Free Report) and Acme United (NYSE:ACU – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.
Risk and Volatility
Avanos Medical has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Acme United has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500.
Earnings & Valuation
This table compares Avanos Medical and Acme United”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avanos Medical | $715.90 million | 1.64 | -$72.90 million | ($1.61) | -15.52 |
| Acme United | $220.55 million | 1.19 | $17.79 million | $2.72 | 24.29 |
Acme United has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Avanos Medical and Acme United, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avanos Medical | 1 | 1 | 0 | 0 | 1.50 |
| Acme United | 0 | 1 | 0 | 0 | 2.00 |
Acme United has a consensus target price of $70.00, indicating a potential upside of 5.96%. Given Acme United’s stronger consensus rating and higher probable upside, analysts clearly believe Acme United is more favorable than Avanos Medical.
Profitability
This table compares Avanos Medical and Acme United’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avanos Medical | -10.39% | 5.39% | 3.97% |
| Acme United | 10.25% | 9.70% | 6.10% |
Institutional and Insider Ownership
95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 62.1% of Acme United shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 29.5% of Acme United shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Acme United beats Avanos Medical on 9 of the 13 factors compared between the two stocks.
About Avanos Medical
Avanos Medical, Inc. develops and markets medical devices and related products, with a focus on digestive health and pain management. Its offerings include enteral feeding tubes and delivery systems, as well as devices used in regional anesthesia and non-opioid pain management. The company’s products are used in hospitals, other health care facilities and home-care settings. Avanos serves customers in the United States and internationally. Avanos traces its history to Halyard Health, which became an independent company after separating from Kimberly-Clark in 2014.
About Acme United
Acme United Corporation is a supplier of cutting, measuring, and safety products for consumers, businesses, and institutions. Its products include scissors, shears, knives, rulers, and other school and office supplies, as well as first aid kits and related medical and safety products. The company sells products under brands including Westcott, Clauss, Camillus, First Aid Only, and PhysiciansCare. Its offerings serve retail, education, office, industrial, and healthcare markets, with sales in the United States and internationally.
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
